BNIP3 and cancer: We hypothesize that although mitochondrial biogenesis is elevated, it is not sufficient to improve mitochondrial quality and prevent muscle loss induced by cancer, thus, does not protect from muscle wasting and reduce mRNA content of important mitophagy promoters such as Bnip3 and Beclin possibly reducing clearance of damaged mitochondria noted by increased red puncta.